Temporary chemotherapy-induced amenorrhea was allowed, provided that the premenopausal status was confirmed by estradiol level within 8 months before the final dose of chemotherapy.
Furthermore, the model does not cover changes in the timing of doses, effects of disease spread before the final dose, or natural immunity.
At this dose level, plasma amyloid-β1 40 wamyloid-β1 40seline levels before dosing on Day 21, before the final dose and in all animals at the time of termination, 4 days after the last dose.
Trough serum samples were obtained before the final dose on the morning of the ninth day followed by sampling at 1, 2, 4, 6, 8, 10, 12, 24, 36, 48, 72, and 96 hrs.
After the first dose at 50 mg/kg, plasma amyloid-β1 40 remamyloid-β1 40he limit of accuremainedntification in the majority of animals for the first 3 days, and in abelowhalf the animalimitfofe dosing on Daccurated before the final dose.
Four doses were administrated at two weeks intervals (day 0, 14, 28 and 31) and blood was collected before each dose, and 11 days after the final dose when the animals were euthanized (day 42).
Three hours before killing the mice, they were administered the final dose and were injected (i.p).
Subjects reported to the study center at least 12 h before dosing and remained there until 30 h after receiving the final dose.
The final dose was administered 10.8 hours (mean) before PCI.
(The child should receive the final dose of the DTaP and IPV before beginning kindergarten).
The final dose of study medication was taken on the day before visit 3 (week 6).
